Ei /lectroconvulsive therapy (ECT) is an effective treatment for melancholia. To obtain therapeutic results it is recommended to ensure adequate seizures; adequacy defined as a seizure duration of at least 25 seconds on EEG (Freeman et al., 1989; American Psychiatric Association, 1990) . Seizure duration reduces progressively during the course of ECTs (Sackeim et al., 1987) . Seizure duration is inversely related to seizure threshold; longer seizure duration is correlated with lower thresholds. Increase in seizure threshold during ECT indicates elevation in tone of GABAergic transmission and is associated with the therapeutic effects of ECT in depression (Sackeim et al., 1987) . Considering the importance of seizure and its duration relative to therapeutic effects of ECT we studied the influence of spacing of ECTs (twice or thrice weekly) on the pattern of reduction of seizure duration.
METHODS
ML atients :Patients of either sex, aged 18-65 years who met the criteria for major depressive disorder with melancholia (DSM III R) (American Psychiatric Association, 1987) formed the sample of this study. Written informed consent was obtained for admission, to receive ECTs and undergo the randomised study of twice versus thrice ECTs weekly. Thirty consecutive consenting patients were randomised into two groups.
ECTs : Modified ECTs (Thiopentone 200-250 mg, Succinylcholine 30-40 mg and Atropine 1.3 mg) were administered thrice a week to one group (thrice weekly). While in the other group (twice weekly), the second ECT of each week comprised only of anaesthesia. Sine wave stimulus from a constant voltage generator (Gangadhar et al., 1988) was administered (120-150 V for 0.6 to 0.8 sees) bilaterally. The stimulus of 120 V and 0.6 sees was set for first session. Increments in the voltage till 150 V and later in duration were made in the event of sub-convulsion. The last convulsive stimulus dose would be used for the next sessions. Motor seizure was monitored (Jain et al., 1989) to ensure 20 seconds of motor seizures, failing which restimuius with increased strength was applied but never more than three stimuli in a session. The maximum seizure duration in that session was recorded. Patients were ventilated with 100% oxygen till they resumed spontaneous respiration.
EEG monitoring : Recording electrode was placed at Cz position of 10-20 system. The reference electrode was placed on the right mastoid and the ground electrode on the forehead. Silver/silver chloride electrodes were used. Single channel EEG was recorded with an amplifier bandwidth of 2-70 Hz. Facility was provided to electronically disconnect the EEG amplifier from the patient during passage of electrical stimulus. EEG recording would resume only after the stimulus was delivered. EEG tracing was terminated by the recording clinician not involved in the study when the record showed isoelectric line or if unequivocal absence of seizure activities lasted for atleast 30 seconds. Single channel EEG traces were coded and labelled without information of any clinical details. Two independent raters, blind to each other's rating as well as to clinical details of the record estimated the seizure duration using a method described earlier (Gangadhar et al, 1982) . Agreement between the two raters on the seizure duration estimates with this procedure has been demonstrated (Jyothi Rao et al., 1982) . For the purpose of this analysis, average seizure duration of these two raters for each ECT session was considered.
Clinical assessments: Patients were assessed by a psychiatrist who was blind to the treatment schedule on the 170-item Hamilton rating scale for depression (HRSD) (Hamilton, 1960) before starting ECTs and at weekly intervals thereafter. The study design required continuation of ECT untill a patient obtained a score of 7 or less on the HRSD on two consecutive weekly assessments or for a maximum period of four weeks. Hence all patients received a minimum of two weeks of treatments a period considered for this analysis. To compare the two groups two way repeat measure analysis of variance (RMANOVA) was used. The alpha was fixed at 5 per cent.
RESULTS
J. hirty patients (15 in each group) completed the four week study. All were available for the first two weeks of treatment. Five patients from the three per week group failed to develop adequate seizures (motor seizure duration 20 seconds) in one or more of sessions in the first two weeks (Fisher's exact probability test, p = 0.027). Such inadequate convulsions of these patients occured in second or later sessions. None of these had an EEG seizure of greater than 25 seconds.
From the rest of 25 patients EEGs of all ECT sessions during first two weeks were available for 22 patients. 10 patients had received ECTs thrice weekly, while 12 patients twice weekly. The sample description is available in Table - 1. The mean seizure duration of the first ECT in the two groups was comparable (t = 0,44, d.f. = 20, N.S.). Two way RMANOVA was used to assess the change in seizure duration from the first ECT through the last ECTs of first and second weeks between the two treatment groups. Significant reductions occured in seizure duration in both groups over occasions (p<0.01). The groups also differed in that the seizure durations became lesser in the thrice weekly group (p < 0.01) ( Table -2 Significant reductions in HRSD scores occured in both groups of patients over the two week period (p<0.01) and no differences emerged between groups (p<0.05) ( Table-3) . Median reduction in seizure duration was 8.25 seconds. Patients who had more than median reduction and those who had less than median reduction (II in each group), were comparable therapeutically and both groups had significant reductions in HRSD scores over the two weeks (p<0.01)(Table-4). Table- 
DISCUSSION
W e have earlier reported that ECT given twice or thrice a week produces comparable antidepressant effects in melancholies over a given time frame (Reddy et al., 1990) supporting an earlier report (McAllister et al., 1987) . Thrice weekly ECTs in melancholies, hence, result in a third additional cost of treatment and attendant risks without significant advantage. There is evidence in clinical and preclinical research that cognitive adverse effects are more with thrice weekly ECTs (McAllister et al.,-1987; Rao et al., 1991) . This study adds to the other demerits of thrice weekly ECTs.
Significantly more number of patients receiving ECTs thrice weekly failed to have 'adequate' seizure in subsequent sessions. ECTs given thrice weekly cummulatively increased the seizure duration when 'adequate' seizures were ensured on all occasions. Therapeutic outcome betweeen the two groups however did not differ. Seizure duration be-came shorter through successive ECT sessions in both the groups, but less so in the twice weekly group. It is hence likely that changes in seizure threshold seen in this study was related to more frequent ECTs. Sackeim et al. (1987) suggest that such increase in seizure threshold is an index of enhancement of GABAergic transmission and is associated with therapeutic effects; patients who responded poorly to ECT failed to develop increases in seizure threshold during ECT course. In this study such asociation was not demonstrable. When patients who had greater reductions in seizure duration (hence increases in seizure threshold) were compared with those who had lesser or no reduction, difference in therapeutic outcome over two week period was not demonstrable (Table-4 ). This issue of the relation between changes in seizure threshold and therapeutic effect needs further investigation.
The results suggest (a) that ECT given thrice weekly is less likely to ensure 'adequate' seizures on all occasions, (b) ECT given twice weekly also produces significant reductions in seizure duration, although this effect was more pronounced if ECTs were given thrice weekly, (c) ECT given twice weekly reduced cummulative seizure duration but without affecting the therapeutic potency, and (d) comparable therapeutic effects were achieved with a third fewer ECT.
